Prescient Therapeutics (PTX) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock PTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Prescient lifts cash to A$12.3M and advances PTX-100 into phase 2 in September quarterOctober 10, 2025 | proactiveinvestors.com.auPrescient Therapeutics Bolsters Cash Reserves and Advances Cancer Therapy TrialsOctober 9, 2025 | tipranks.comDr Boreham’s Crucible: One clear shot on goal for this cancer drug hopefulSeptember 22, 2025 | msn.comPrescient Therapeutics Issues New Unquoted Equity SecuritiesSeptember 1, 2025 | tipranks.comPrescient Therapeutics Lists New Securities on ASXAugust 29, 2025 | tipranks.comPrescient Therapeutics Completes $3 Million Share Placement to Advance Cancer TherapiesAugust 29, 2025 | tipranks.comPrescient Therapeutics Reports Financial Results with Focus on R&D InvestmentAugust 20, 2025 | tipranks.comPrescient Therapeutics Releases Corporate Governance StatementAugust 20, 2025 | tipranks.comPrescient Therapeutics Expands Market Presence with New Securities QuotationAugust 11, 2025 | tipranks.comPrescient Therapeutics Director Increases ShareholdingAugust 11, 2025 | tipranks.comPrescient Therapeutics Director Increases Stake in Share Purchase PlanAugust 11, 2025 | tipranks.comPrescient Therapeutics Director Increases Stake in CompanyAugust 11, 2025 | tipranks.comPrescient Therapeutics takes cap raise to $9.8m to fast-track cancer treatmentJuly 31, 2025 | msn.comVCU Massey pioneers clinical trial of novel GGT-1 inhibitor PTX-100July 26, 2025 | msn.comThis rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solutionJuly 18, 2025 | msn.comPitt Street sees strong upside as Prescient advances phase 2a cancer trialJuly 18, 2025 | msn.comLong Shortz with Prescient Therapeutics: First US trial site launches for PTX-100July 16, 2025 | msn.comPrescient starts US recruitment in Phase 2a trial of PTX-100 for patients with rare blood cancerJuly 16, 2025 | msn.comPrescient Therapeutics Extends Securities Issue DeadlineJuly 14, 2025 | tipranks.comNew Prescient leadership to drive PTX-100 development in rare blood cancerJuly 11, 2025 | msn.comVital Signs Podcast: Why this clinical-stage oncology company is “first in class”July 2, 2025 | msn.comPrescient advances new therapies for hard-to-treat cancersJune 27, 2025 | msn.comPrescient Therapeutics CEO highlights PTX-100 progress in RAS-Driven cancer trialJune 25, 2025 | msn.comPrescient doses first patient in Phase 2a cancer trialMay 30, 2025 | msn.comPrescient Therapeutics Advances with Phase 2A Trial of PTX-100May 28, 2025 | tipranks.comPrescient Therapeutics Highlights Forward-Looking Risks in Cancer Therapy DevelopmentMay 20, 2025 | tipranks.comPrescient Therapeutics Director Increases StakeMay 6, 2025 | tipranks.comDirector’s Acquisition Signals Confidence in Prescient TherapeuticsMay 1, 2025 | tipranks.comPrescient Therapeutics Advances Cancer Therapy with FDA Fast TrackApril 16, 2025 | tipranks.comWednesday's HotCopper Trends: Galan bags funds, Prescient's FDA tick | April 16, 2025April 15, 2025 | msn.comHere's Why We're Watching Prescient Therapeutics' (ASX:PTX) Cash Burn SituationApril 14, 2025 | finance.yahoo.comPrescient Therapeutics Appoints Melanie Farris as Non-Executive DirectorApril 9, 2025 | tipranks.comPrescient Therapeutics to Host Investor Briefing on PTX-100 ProgressMarch 30, 2025 | tipranks.comPleco Therapeutics Announces Positive Outcome of Pre-IND meeting with FDA for PTX-252 in Acute Myeloid LeukaemiaMarch 26, 2025 | markets.businessinsider.comHealth Check: LTR Pharma finds fast-track path to US erectile dysfunction marketMarch 25, 2025 | msn.comPrescient Therapeutics opens first clinical site for Phase 2a PTX-100 trial in cutaneous T-cell lymphomaMarch 25, 2025 | proactiveinvestors.comPrescient Therapeutics Appoints New Chief Medical Officer to Drive Cancer Therapy InnovationsMarch 24, 2025 | tipranks.comPrescient Therapeutics Director Increases ShareholdingMarch 16, 2025 | tipranks.comPrescient Therapeutics embarks on board chair transition process as chair retiresMarch 11, 2025 | au.investing.comPrescient Therapeutics Reports Decreased Losses Amid Revenue DropFebruary 20, 2025 | tipranks.comPrescient Therapeutics Initiates Phase 2 Trial and Strengthens LeadershipJanuary 30, 2025 | tipranks.comPrescient Therapeutics resumes OmniCAR program after resolving technical challengesJanuary 22, 2025 | au.investing.comPrescient Therapeutics Overcomes OmniCAR Technical Challenges to Advance Cancer TreatmentJanuary 22, 2025 | tipranks.comPrescient Therapeutics Issues Unquoted Equity SecuritiesJanuary 21, 2025 | tipranks.comPrescient Therapeutics Reports Expiry of 1 Million OptionsJanuary 12, 2025 | tipranks.comPrescient Therapeutics Gains FDA Approval for PTX-100 TrialDecember 22, 2024 | tipranks.comPrescient Therapeutics Appoints New CEO for GrowthDecember 16, 2024 | tipranks.comPrescient Therapeutics Director Increases Stake in Future GrowthDecember 11, 2024 | tipranks.comPrescient Therapeutics Expands Cancer Treatment InnovationsDecember 3, 2024 | tipranks.comPrescient Therapeutics Warns of Investment RisksNovember 14, 2024 | markets.businessinsider.com Get Prescient Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PTX Media Mentions By Week PTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PTX News Sentiment▼-0.630.72▲Average Medical News Sentiment PTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PTX Articles This Week▼21▲PTX Articles Average Week Get the Latest News and Ratings for PTX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Prescient Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Bioventix News 4basebio News Scancell News Medicenna Therapeutics News Hemogenyx Pharmaceuticals News Hyperion DeFi News Sernova News ImmuPharma News Covalon Technologies News hVIVO News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:PTX) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredThe End of Elon Musk…?While headlines point to collapsing sales and fading tax credits, tech analyst Jeff Brown says Tesla is on the...Brownstone Research | SponsoredWhy Wall Street is piling into the “Debasement Trade”Wall Street is piling into what insiders are calling the “Debasement Trade” — and according to former Goldman ...Stansberry Research | SponsoredBuy this stock before Tesla’s November 6 announcementThe End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredThe 7 Warning Signals Flashing Red Right NowA free report revealing the 7 key indicators that have predicted every major economic collapse since 1929. ...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prescient Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Prescient Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
